Citigroup Sells OneMain Instead of Having IPO
Citigroup has announced a definitive agreement with Springleaf Holdings regarding the sale of OneMain Financial Holdings for $4.25 billion.
Citigroup Inc. (NYSE: C) announced Tuesday morning that it has reached a definitive agreement with Springleaf Holdings LLC (NYSE: LEAF) regarding the sale of OneMain Financial Holdings. The purchase price for the transaction was set at $4.25 billion, and it is expected to close in the third quarter of 2015.
In the fall of 2014, OneMain filed with the Securities and Exchange Commission (SEC) for an initial public offering, but no definitive terms came from it. Originally, OneMain was planned as a spin-off from Citigroup.
OneMain’s network consists of a local front-end workforce of approximately 4,100 employees and is supported centrally by approximately 1,100 employees, with additional functional support provided by Citigroup. The captive insurance business, Citi Assurance Services, or CAS, is staffed by an additional workforce of approximately 215 employees.
Citi Holdings was established in 2009 and consists of businesses and asset portfolios that Citigroup has determined are not central to its core franchise, one of these being OneMain Financial. Since its creation, it has sold over 60 businesses and reduced assets in Citi Holdings by more than $700 billion. At the end of 2014, Citi Holdings’ assets represented approximately 5% of total Citigroup assets, down from a peak of more than 30%.
Citigroup CEO Michael Corbat commented on OneMain:
OneMain is a great business with talented people, who will now become part of a leading personal finance company. While this business didn’t fit our strategy, it serves customers who deserve and need credit. Today’s announcement is a significant milestone in the simplification of our company and we continue to focus on delivering the potential of our franchise for our clients and shareholders.
Shares of Citigroup were up 0.4% at $53.71 in the first two hours of trading Tuesday. The stock has a consensus analyst price target of $60.63 and a 52-week trading range of $45.18 to $56.95.
Springleaf shares shot up 28% at $48.75. The consensus price target is $37.61, and the 52-week trading range is $20.54 to $52.48.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
